关注
Seth Heldenbrand
标题
引用次数
年份
A curriculum crosswalk of the core entrustable professional activities for new pharmacy graduates
TJ Kanmaz, NS Culhane, LA Berenbrok, J Jarrett, EL Johanson, ...
American Journal of Pharmaceutical Education 84 (11), 8077, 2020
152020
A multisite, longitudinal study assessing prevalence of depression in student pharmacists
KL MacCamy, SD Heldenbrand, JD Robinson
American Journal of Pharmaceutical Education 88 (2), 100634, 2024
2024
A paradigm shift in US experiential pharmacy education accelerated by the COVID-19 pandemic
KA Fuller, SD Heldenbrand, MD Smith, DR Malcom
American Journal of Pharmaceutical Education 84 (6), ajpe8149, 2020
802020
APPE evaluations are positively associated with MMI, pre-pharmacy GPA and pharmacy GPA
SD Heldenbrand, LE Dayer, BC Martin, C O’Brien, AN Choi, PO Gubbins, ...
American Journal of Pharmaceutical Education 82 (7), 6326, 2018
142018
Assessing the medication adherence app marketplace from the health professional and consumer vantage points
LE Dayer, R Shilling, M Van Valkenburg, BC Martin, PO Gubbins, ...
JMIR mHealth and uHealth 5 (4), e6582, 2017
482017
Assessment of medication adherence app features, functionality, and health literacy level and the creation of a searchable Web-based adherence app resource for health care …
S Heldenbrand, BC Martin, PO Gubbins, K Hadden, C Renna, R Shilling, ...
Journal of the American Pharmacists Association 56 (3), 293-302, 2016
562016
Becoming more holistic: a literature review of nonacademic factors in the admissions process of colleges and schools of pharmacy and other health professions
AN Choi, SK Flowers, SD Heldenbrand
Currents in Pharmacy Teaching and Learning 10 (10), 1429-1437, 2018
132018
Clinically relevant drug interactions of current antifungal agents
PO Gubbins, S Heldenbrand
Mycoses 53 (2), 95-113, 2010
852010
Evaluation of APPE Hesitation Failure Among Preceptors
L Fleming, A Pate, S Heldenbrand, LE Dayer, A Rhett
American Journal of Pharmaceutical Education 87 (8), 2023
2023
Extended Comparison of Therapeutic Treatment Outcomes of De Novo Liver and Kidney Transplant Recipients with Generic Tacrolimus (Sandoz (TM)) or Brand Name (Prograf (R))
S Heldenbrand, GD Jones, J Bornhorst, N Payakachat
AMERICAN JOURNAL OF TRANSPLANTATION 12, 240-240, 2012
52012
Meeting report: consensus recommendations for a research agenda to address immunosuppressant nonadherence in organ transplantation
AQ Maldonado, P WestThielke, MA Dew, JD Peipert, S Heldenbrand, ...
Clinical Transplantation 32 (9), e13362, 2018
122018
Multicenter evaluation of efficacy and safety of lowdose versus highdose valganciclovir for prevention of cytomegalovirus disease in donor and recipient positive (D+/R+ …
S Heldenbrand, C Li, RP Cross, KA DePiero, TB Dick, K Ferguson, M Kim, ...
Transplant Infectious Disease 18 (6), 904-912, 2016
352016
Multiple mini-interview performance predicts academic difficulty in the PharmD curriculum
SD Heldenbrand, SK Flowers, BJ Bordelon, PO Gubbins, C O’Brien, ...
American Journal of Pharmaceutical Education 80 (2), 27, 2016
382016
Navigating the flooded adherence app marketplace: rating the quality of medication adherence apps
S Heldenbrand, L Dayer, C Renna, R Shilling, B Martin
Abstract presented at American Pharmacists Association Annual Meeting. San …, 2015
42015
Nonadherence to therapy after adult solid organ transplantation: a focus on risks and mitigation strategies
IC Doyle, AQ Maldonado, S Heldenbrand, EM Tichy, J Trofe-Clark
American Journal of Health-System Pharmacy 73 (12), 909-920, 2016
192016
Patient self-efficacy and satisfaction after medication education following solid organ transplantation
SD Heldenbrand, LE Turnbow, N Payakachat
Pharmacotherapy 30 (10), 425e, 2010
52010
Prevention of Cytomegalovirus with Valganciclovir 450mg Daily vs. 900mg Daily in Intermediate Risk Renal Transplant Recipients (D-/R plus); a Multicenter Safety and Efficacy …
S Gabardi, R Cross, K DePiero, T Dick, K Ferguson, E Newkirk, J Park, ...
AMERICAN JOURNAL OF TRANSPLANTATION 13, 210-210, 2013
32013
Seizures as a potential complication of treatment with simeprevir and sofosbuvir
G Syal, SD Heldenbrand, A Duarte-Rojo
American journal of therapeutics 23 (2), e570-e571, 2016
52016
Smartphone medication adherence apps: potential benefits to patients and providers
L Dayer, S Heldenbrand, P Anderson, PO Gubbins, BC Martin
Journal of the American Pharmacists Association 53 (2), 172-181, 2013
5802013
Smartphone medication adherence apps: potential benefits to patients and providers: response to Aungst
L Dayer, S Heldenbrand, P Anderson, PO Gubbins, BC Martin
Journal of the American Pharmacists Association 53 (4), 345, 2013
302013
系统目前无法执行此操作,请稍后再试。
文章 1–20